B1SX34:BVMF
Boston Scientific Corp Brazilian Depositary Receipt
R$56.59
0.00%
(0.00) 1D
Sep 30, 10:30:02 AM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for B1SX34...
Mkt. cap
62.65B
Avg. vol.
981.00
Volume
0.00
52-wk high
R$140.91
52-wk low
R$50.29
Shares outstanding
1.45B
No. of employees
59K
Mkt. cap
62.65B
Avg. vol.
981.00
Volume
0.00
52-wk high
R$140.91
52-wk low
R$50.29
Shares outstanding
1.45B
No. of employees
59K
News stories
From web sources and news partners
TradingView
·
12 hours ago
Elutia Receives $8 Million Payment From Boston Scientific Company Now Fully Funded Into 2029
Investing.com Canada
·
13 hours ago
Elutia receives $8 million escrow from Boston Scientific sale By Investing.com
The Manila Times
·
13 hours ago
Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029
Profile
Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
The company is known for developing the Taxus Stent, a drug-eluting stent that is used to open clogged arteries. The company acquired Cameron Health in June 2012 and began to offer a minimally invasive implantable cardioverter-defibrillator called the EMBLEM subcutaneous implantable defibrillator.
BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. Wikipedia
About Boston Scientific Corp Brazilian Depositary Receipt
CEOMichael F. Mahoney
Employees59K
FoundedJun 29, 1979
HeadquartersMarlborough, Massachusetts, United States
SectorMedical device
Websitebostonscientific.com